Patent · US Active

Oral dosage form

US11786476B2 · kind B2 · utility

0Cited by

2References

22Claims

0Family size

Assignee

UNIVERSITEIT GENT · BE

Inventors

Chris Vervaet · Kachtem, BE
Jean Paul Remon · Melle, BE
Glenn Verstraete · Rollegem-Kapelle, BE

Key dates

Filing date	Jun 11, 2021
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Dec 9, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.